Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Dermatophytosis Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Rx
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Drugs for Dermatophytosis Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Dermatophytosis Market Perspective (2018-2029)
2.2 Drugs for Dermatophytosis Growth Trends by Region
2.2.1 Global Drugs for Dermatophytosis Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drugs for Dermatophytosis Historic Market Size by Region (2018-2024)
2.2.3 Drugs for Dermatophytosis Forecasted Market Size by Region (2024-2029)
2.3 Drugs for Dermatophytosis Market Dynamics
2.3.1 Drugs for Dermatophytosis Industry Trends
2.3.2 Drugs for Dermatophytosis Market Drivers
2.3.3 Drugs for Dermatophytosis Market Challenges
2.3.4 Drugs for Dermatophytosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Dermatophytosis Players by Revenue
3.1.1 Global Top Drugs for Dermatophytosis Players by Revenue (2018-2024)
3.1.2 Global Drugs for Dermatophytosis Revenue Market Share by Players (2018-2024)
3.2 Global Drugs for Dermatophytosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drugs for Dermatophytosis Revenue
3.4 Global Drugs for Dermatophytosis Market Concentration Ratio
3.4.1 Global Drugs for Dermatophytosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Dermatophytosis Revenue in 2022
3.5 Drugs for Dermatophytosis Key Players Head office and Area Served
3.6 Key Players Drugs for Dermatophytosis Product Solution and Service
3.7 Date of Enter into Drugs for Dermatophytosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Dermatophytosis Breakdown Data by Type
4.1 Global Drugs for Dermatophytosis Historic Market Size by Type (2018-2024)
4.2 Global Drugs for Dermatophytosis Forecasted Market Size by Type (2024-2029)
5 Drugs for Dermatophytosis Breakdown Data by Application
5.1 Global Drugs for Dermatophytosis Historic Market Size by Application (2018-2024)
5.2 Global Drugs for Dermatophytosis Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Drugs for Dermatophytosis Market Size (2018-2029)
6.2 North America Drugs for Dermatophytosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Drugs for Dermatophytosis Market Size by Country (2018-2024)
6.4 North America Drugs for Dermatophytosis Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drugs for Dermatophytosis Market Size (2018-2029)
7.2 Europe Drugs for Dermatophytosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Drugs for Dermatophytosis Market Size by Country (2018-2024)
7.4 Europe Drugs for Dermatophytosis Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Dermatophytosis Market Size (2018-2029)
8.2 Asia-Pacific Drugs for Dermatophytosis Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Drugs for Dermatophytosis Market Size by Region (2018-2024)
8.4 Asia-Pacific Drugs for Dermatophytosis Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drugs for Dermatophytosis Market Size (2018-2029)
9.2 Latin America Drugs for Dermatophytosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Drugs for Dermatophytosis Market Size by Country (2018-2024)
9.4 Latin America Drugs for Dermatophytosis Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Dermatophytosis Market Size (2018-2029)
10.2 Middle East & Africa Drugs for Dermatophytosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Drugs for Dermatophytosis Market Size by Country (2018-2024)
10.4 Middle East & Africa Drugs for Dermatophytosis Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Drugs for Dermatophytosis Introduction
11.1.4 Novartis Revenue in Drugs for Dermatophytosis Business (2018-2024)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Drugs for Dermatophytosis Introduction
11.2.4 Pfizer Revenue in Drugs for Dermatophytosis Business (2018-2024)
11.2.5 Pfizer Recent Development
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Company Detail
11.3.2 Sanofi-Aventis Business Overview
11.3.3 Sanofi-Aventis Drugs for Dermatophytosis Introduction
11.3.4 Sanofi-Aventis Revenue in Drugs for Dermatophytosis Business (2018-2024)
11.3.5 Sanofi-Aventis Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Drugs for Dermatophytosis Introduction
11.4.4 Merck Revenue in Drugs for Dermatophytosis Business (2018-2024)
11.4.5 Merck Recent Development
11.5 Enzon Pharmaceuticals
11.5.1 Enzon Pharmaceuticals Company Detail
11.5.2 Enzon Pharmaceuticals Business Overview
11.5.3 Enzon Pharmaceuticals Drugs for Dermatophytosis Introduction
11.5.4 Enzon Pharmaceuticals Revenue in Drugs for Dermatophytosis Business (2018-2024)
11.5.5 Enzon Pharmaceuticals Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Drugs for Dermatophytosis Introduction
11.6.4 Bayer Revenue in Drugs for Dermatophytosis Business (2018-2024)
11.6.5 Bayer Recent Development
11.7 Astellas Pharma
11.7.1 Astellas Pharma Company Detail
11.7.2 Astellas Pharma Business Overview
11.7.3 Astellas Pharma Drugs for Dermatophytosis Introduction
11.7.4 Astellas Pharma Revenue in Drugs for Dermatophytosis Business (2018-2024)
11.7.5 Astellas Pharma Recent Development
11.8 GSK
11.8.1 GSK Company Detail
11.8.2 GSK Business Overview
11.8.3 GSK Drugs for Dermatophytosis Introduction
11.8.4 GSK Revenue in Drugs for Dermatophytosis Business (2018-2024)
11.8.5 GSK Recent Development
11.9 Abbott
11.9.1 Abbott Company Detail
11.9.2 Abbott Business Overview
11.9.3 Abbott Drugs for Dermatophytosis Introduction
11.9.4 Abbott Revenue in Drugs for Dermatophytosis Business (2018-2024)
11.9.5 Abbott Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Drugs for Dermatophytosis Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Rx
Table 3. Key Players of OTC
Table 4. Global Drugs for Dermatophytosis Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Drugs for Dermatophytosis Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Drugs for Dermatophytosis Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Drugs for Dermatophytosis Market Share by Region (2018-2024)
Table 8. Global Drugs for Dermatophytosis Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Drugs for Dermatophytosis Market Share by Region (2024-2029)
Table 10. Drugs for Dermatophytosis Market Trends
Table 11. Drugs for Dermatophytosis Market Drivers
Table 12. Drugs for Dermatophytosis Market Challenges
Table 13. Drugs for Dermatophytosis Market Restraints
Table 14. Global Drugs for Dermatophytosis Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Drugs for Dermatophytosis Market Share by Players (2018-2024)
Table 16. Global Top Drugs for Dermatophytosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Dermatophytosis as of 2022)
Table 17. Ranking of Global Top Drugs for Dermatophytosis Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Drugs for Dermatophytosis Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Drugs for Dermatophytosis Product Solution and Service
Table 21. Date of Enter into Drugs for Dermatophytosis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drugs for Dermatophytosis Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Drugs for Dermatophytosis Revenue Market Share by Type (2018-2024)
Table 25. Global Drugs for Dermatophytosis Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Drugs for Dermatophytosis Revenue Market Share by Type (2024-2029)
Table 27. Global Drugs for Dermatophytosis Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Drugs for Dermatophytosis Revenue Market Share by Application (2018-2024)
Table 29. Global Drugs for Dermatophytosis Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Drugs for Dermatophytosis Revenue Market Share by Application (2024-2029)
Table 31. North America Drugs for Dermatophytosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Drugs for Dermatophytosis Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Drugs for Dermatophytosis Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Drugs for Dermatophytosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Drugs for Dermatophytosis Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Drugs for Dermatophytosis Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Drugs for Dermatophytosis Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Drugs for Dermatophytosis Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Drugs for Dermatophytosis Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Drugs for Dermatophytosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Drugs for Dermatophytosis Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Drugs for Dermatophytosis Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Drugs for Dermatophytosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Drugs for Dermatophytosis Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Drugs for Dermatophytosis Market Size by Country (2024-2029) & (US$ Million)
Table 46. Novartis Company Detail
Table 47. Novartis Business Overview
Table 48. Novartis Drugs for Dermatophytosis Product
Table 49. Novartis Revenue in Drugs for Dermatophytosis Business (2018-2024) & (US$ Million)
Table 50. Novartis Recent Development
Table 51. Pfizer Company Detail
Table 52. Pfizer Business Overview
Table 53. Pfizer Drugs for Dermatophytosis Product
Table 54. Pfizer Revenue in Drugs for Dermatophytosis Business (2018-2024) & (US$ Million)
Table 55. Pfizer Recent Development
Table 56. Sanofi-Aventis Company Detail
Table 57. Sanofi-Aventis Business Overview
Table 58. Sanofi-Aventis Drugs for Dermatophytosis Product
Table 59. Sanofi-Aventis Revenue in Drugs for Dermatophytosis Business (2018-2024) & (US$ Million)
Table 60. Sanofi-Aventis Recent Development
Table 61. Merck Company Detail
Table 62. Merck Business Overview
Table 63. Merck Drugs for Dermatophytosis Product
Table 64. Merck Revenue in Drugs for Dermatophytosis Business (2018-2024) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Enzon Pharmaceuticals Company Detail
Table 67. Enzon Pharmaceuticals Business Overview
Table 68. Enzon Pharmaceuticals Drugs for Dermatophytosis Product
Table 69. Enzon Pharmaceuticals Revenue in Drugs for Dermatophytosis Business (2018-2024) & (US$ Million)
Table 70. Enzon Pharmaceuticals Recent Development
Table 71. Bayer Company Detail
Table 72. Bayer Business Overview
Table 73. Bayer Drugs for Dermatophytosis Product
Table 74. Bayer Revenue in Drugs for Dermatophytosis Business (2018-2024) & (US$ Million)
Table 75. Bayer Recent Development
Table 76. Astellas Pharma Company Detail
Table 77. Astellas Pharma Business Overview
Table 78. Astellas Pharma Drugs for Dermatophytosis Product
Table 79. Astellas Pharma Revenue in Drugs for Dermatophytosis Business (2018-2024) & (US$ Million)
Table 80. Astellas Pharma Recent Development
Table 81. GSK Company Detail
Table 82. GSK Business Overview
Table 83. GSK Drugs for Dermatophytosis Product
Table 84. GSK Revenue in Drugs for Dermatophytosis Business (2018-2024) & (US$ Million)
Table 85. GSK Recent Development
Table 86. Abbott Company Detail
Table 87. Abbott Business Overview
Table 88. Abbott Drugs for Dermatophytosis Product
Table 89. Abbott Revenue in Drugs for Dermatophytosis Business (2018-2024) & (US$ Million)
Table 90. Abbott Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs for Dermatophytosis Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Drugs for Dermatophytosis Market Share by Type: 2022 VS 2029
Figure 3. Rx Features
Figure 4. OTC Features
Figure 5. Global Drugs for Dermatophytosis Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Drugs for Dermatophytosis Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Drugs for Dermatophytosis Report Years Considered
Figure 11. Global Drugs for Dermatophytosis Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Drugs for Dermatophytosis Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Drugs for Dermatophytosis Market Share by Region: 2022 VS 2029
Figure 14. Global Drugs for Dermatophytosis Market Share by Players in 2022
Figure 15. Global Top Drugs for Dermatophytosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Dermatophytosis as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Drugs for Dermatophytosis Revenue in 2022
Figure 17. North America Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Drugs for Dermatophytosis Market Share by Country (2018-2029)
Figure 19. United States Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Drugs for Dermatophytosis Market Share by Country (2018-2029)
Figure 23. Germany Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Drugs for Dermatophytosis Market Share by Region (2018-2029)
Figure 31. China Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Drugs for Dermatophytosis Market Share by Country (2018-2029)
Figure 39. Mexico Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Drugs for Dermatophytosis Market Share by Country (2018-2029)
Figure 43. Turkey Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Drugs for Dermatophytosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Novartis Revenue Growth Rate in Drugs for Dermatophytosis Business (2018-2024)
Figure 46. Pfizer Revenue Growth Rate in Drugs for Dermatophytosis Business (2018-2024)
Figure 47. Sanofi-Aventis Revenue Growth Rate in Drugs for Dermatophytosis Business (2018-2024)
Figure 48. Merck Revenue Growth Rate in Drugs for Dermatophytosis Business (2018-2024)
Figure 49. Enzon Pharmaceuticals Revenue Growth Rate in Drugs for Dermatophytosis Business (2018-2024)
Figure 50. Bayer Revenue Growth Rate in Drugs for Dermatophytosis Business (2018-2024)
Figure 51. Astellas Pharma Revenue Growth Rate in Drugs for Dermatophytosis Business (2018-2024)
Figure 52. GSK Revenue Growth Rate in Drugs for Dermatophytosis Business (2018-2024)
Figure 53. Abbott Revenue Growth Rate in Drugs for Dermatophytosis Business (2018-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed